Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
VELCADE® (bortezomib) for Injection
VELCADE is a treatment for Multiple Myeloma and Mantle Cell Lymphoma. Find important information such as side effects and how to dose. See Important Safety Information and Prescribing Information.
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for velcade.com: 99.84.108.8, 99.84.108.43, 99.84.108.82, 99.84.108.94. Moreover, DNS used with this website include ns-1041.awsdns-02.org, ns-1583.awsdns-05.co.uk, ns-396.awsdns-49.com, ns-701.awsdns-23.net. Subnet identifier ranges from 99.84.0.0 to 99.84.255.255. Classless Inter-Domain Routing (CIDR) is 99.84.0.0/16. ARIN net type is Reallocated.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns-1041.awsdns-02.org
ns-1583.awsdns-05.co.uk
ns-396.awsdns-49.com
ns-701.awsdns-23.net
{{value}}
2002-03-18
2022-03-18
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of velcade.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2022-03-18. According to open source data, you can reach the owner at adminmaster@takeda.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Japan.
Jul 07, 2016
Jun 18, 2017
Jun 01, 2018
Jul 23, 2020
N/A
N/A
N/A
N/A
N/A
534
N/A
N/A
N/A
N/A
N/A
N/A